Literature DB >> 20228843

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.

K-S Lee1, Y-S Lee, J-M Lee, K Ito, S Cinghu, J-H Kim, J-W Jang, Y-H Li, Y-M Goh, X-Z Chi, H Wee, H-W Lee, A Hosoya, J-H Chung, J-J Jang, J K Kundu, Y-J Surh, W-J Kim, Y Ito, H-S Jung, S-C Bae.   

Abstract

Human lung adenocarcinoma, the most prevalent form of lung cancer, is characterized by many molecular abnormalities. K-ras mutations are associated with the initiation of lung adenocarcinomas, but K-ras-independent mechanisms may also initiate lung tumors. Here, we find that the runt-related transcription factor Runx3 is essential for normal murine lung development and is a tumor suppressor that prevents lung adenocarcinoma. Runx3-/- mice, which die soon after birth, exhibit alveolar hyperplasia. Importantly, Runx3-/- bronchioli exhibit impaired differentiation, as evidenced by the accumulation of epithelial cells containing specific markers for both alveolar (that is SP-B) and bronchiolar (that is CC10) lineages. Runx3-/- epithelial cells also express Bmi1, which supports self-renewal of stem cells. Lung adenomas spontaneously develop in aging Runx3+/- mice ( approximately 18 months after birth) and invariably exhibit reduced levels of Runx3. As K-ras mutations are very rare in these adenomas, Runx3+/- mice provide an animal model for lung tumorigenesis that recapitulates the preneoplastic stage of human lung adenocarcinoma development, which is independent of K-Ras mutation. We conclude that Runx3 is essential for lung epithelial cell differentiation, and that downregulation of Runx3 is causally linked to the preneoplastic stage of lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228843     DOI: 10.1038/onc.2010.79

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

2.  Identification of RUNX3 as a component of the MST/Hpo signaling pathway.

Authors:  Boram Min; Min-Kyu Kim; Joo-Won Zhang; Jiyeon Kim; Kwang-Chul Chung; Byung-Chul Oh; Gary S Stein; Yong-Hee Lee; Andre J van Wijnen; Suk-Chul Bae
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 3.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

4.  RUNX3-dependent oxidative epithelial-to-mesenchymal transition in methamphetamine-induced chronic lung injury.

Authors:  Lin Shi; Bing-Yang Liu; Xin Wang; Mei-Jia Zhu; Lei Chen; Ming-Yuan Zhou; Ying-Jian Gu; Lin Cheng; Yun Wang
Journal:  Cell Stress Chaperones       Date:  2020-07-17       Impact factor: 3.667

5.  Loss of RUNX1 is associated with aggressive lung adenocarcinomas.

Authors:  Jon Ramsey; Kelly Butnor; Zhihua Peng; Tim Leclair; Jos van der Velden; Gary Stein; Jane Lian; C Matthew Kinsey
Journal:  J Cell Physiol       Date:  2017-11-01       Impact factor: 6.384

6.  Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-01       Impact factor: 7.396

7.  IGFBP-3 is a metastasis suppression gene in prostate cancer.

Authors:  Hemal H Mehta; Qinglei Gao; Colette Galet; Vladislava Paharkova; Junxiang Wan; Jonathan Said; Joanne J Sohn; Gregory Lawson; Pinchas Cohen; Laura J Cobb; Kuk-Wha Lee
Journal:  Cancer Res       Date:  2011-06-22       Impact factor: 12.701

8.  Lung cancer stem cell: new insights on experimental models and preclinical data.

Authors:  Caroline Rivera; Sofia Rivera; Yohann Loriot; Marie-Catherine Vozenin; Eric Deutsch
Journal:  J Oncol       Date:  2010-12-16       Impact factor: 4.375

9.  Abnormal liver differentiation and excessive angiogenesis in mice lacking Runx3.

Authors:  Jong-Min Lee; Dong-Joon Lee; Suk-Chul Bae; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2013-01-31       Impact factor: 4.304

10.  Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.

Authors:  Reem Eldawud; Alixandra Wagner; Chenbo Dong; Neha Gupta; Yon Rojanasakul; George O'Doherty; Todd A Stueckle; Cerasela Zoica Dinu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-07-15       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.